Univ. Prof. Dr. Richard Greil

Head of the IIIrd Medical Department Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases at the Paracelsus Medical University Hospital Salzburg.
Laboratory of Immunological and Molecular Cancer Research (LIMCR).

list of publications

Antimyeloma activity of the sesquiterpene lactone cnicin: impact on Pim-2 kinase as a novel therapeutic target.

Jöhrer K, Obkircher M, Neureiter D, Parteli J, Zelle-Rieser C, Maizner E, Kern J, Hermann M, Hamacher F, Merkel O, Wacht N, Zidorn C, Scheideler M, Greil R.

Mol Med (Berl). 1 Jun 2012; 90(6)681-93.

Chemokine-dependent B cell-T cell interactions in chronic lymphocytic leukemia and multiple myeloma - targets for therapeutic intervention?

Jöhrer K, Hofbauer SW, Zelle-Rieser C, Greil R, Hartmann TN.

Expert Opin Biol Ther. 1 Apr 2012; 12(4)425-41.

The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells.

Nevo I, Sagi-Assif O, Meshel T, Ben-Baruch A, Jöhrer K, Greil R, Trejo LE, Kharenko O, Feinmesser M, Yron I, Witz IP.

Cancer Lett 8 Jan 2009; 273(1)127-39.

Tumour-immune cell interactions modulated by chemokines.

Jöhrer K, Pleyer L, Olivier A, Maizner E, Zelle-Rieser C, Greil R.

Expert Opin Biol Ther. 22 Dec 2008; 8(3)269-90.

A role of TRAIL in killing osteoblasts by myeloma cells.

Tinhofer I, Biedermann R, Krismer M, Crazzolara R, Greil R.

FASEB J. 1 Apr 2006; 20(6)759-61. Epub 2006 Jan 25.

IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses.

Falkensammer C, Johrer K, Gander H, Ramoner R, Putz T, Rahm A, Greil R, Bartsch G, Thurnher M.

Cancer Immunol Immunother. 28 Jan 2006; 28-1-2006()1-10.

Polyacetylenes from the Apiaceae vegetables carrot, celery, fennel, parsley, and parsnip and their cytotoxic activities.

Zidorn C, Johrer K, Ganzera M, Schubert B, Sigmund EM, Mader J, Greil R, Ellmerer EP, Stuppner H.

J Agric Food Chem. 6 Apr 2005; 53(7)2518-23.

Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma.

Johrer K, Zelle-Rieser C, Perathoner A, Moser P, Hager M, Ramoner R, Gander H, Holtl L, Bartsch G, Greil R, Thurnher M.

Clin Cancer Res. 1 Apr 2005; 11(7)2459-65.

Is higher income and educational status associated with poorer outcome in patients with Hodgkin's disease?

Holzner B, Fischhofer M, Kemmler G, Kopp M, Sperner-Unterweger B, Krugmann J, Dirnhofer S, Greil R.

Eur J Haematol. 1 Nov 2004; 73(5)318-24.

Quality of life of patients with chronic lymphocytic leukemia: results of a longitudinal investigation over 1 yr.

Holzner B, Kemmler G, Kopp M, Nguyen-Van-Tam D, Sperner-Unterweger B, Greil R.

Eur J Haematol. 1 Jun 2004; 72(6)381-9.

Unfavourable prognosis of patients with trisomy 18q21 detected by fluorescence in situ hybridisation in t(11;18) negative, surgically resected, gastrointestinal B cell lymphomas.

Krugmann J, Tzankov A, Dirnhofer S, Fend F, Greil R, Siebert R, Erdel M.

J Clin Pathol. 1 Apr 2004; 57(4)360-4.

Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-alpha via TNF receptor 2 and autocrine up-regulation of MCP-1.

Johrer K, Janke K, Krugmann J, Fiegl M, Greil R.

Clin Cancer Res. 15 Mar 2004; 10(6)1901-10.

Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets, and therapeutic tools.

Greil R, Anether G, Johrer K, Tinhofer I.

J Leukoc Biol. 1 Sep 2003; 74(3)311-30.

Tetrocarcin-A--induced ER stress mediates apoptosis in B-CLL cells via a Bcl-2--independent pathway.

Anether G, Tinhofer I, Senfter M, Greil R.

Blood. 1 Jun 2003; 101(11)4561-8. Epub 2003 Jan 30.

Prognostic significance of CD20 expression in classical Hodgkin lymphoma: a clinicopathological study of 119 cases.

Tzankov A, Krugmann J, Fend F, Fischhofer M, Greil R, Dirnhofer S.

Clin Cancer Res. 1 Apr 2003; 9(4)1381-6.

Tuning the rheostat of the myelopoietic system via Fas and TRAIL.

Greil R, Anether G, Johrer K, Tinhofer I.

Crit Rev Immunol. 1 Jan 2003; 23(4)301-22.

Stressful death of T-ALL tumor cells after treatment with the anti-tumor agent Tetrocarcin-A.

Tinhofer I, Anether G, Senfter M, Pfaller K, Bernhard D, Hara M, Greil R.

FASEB J. 1 Aug 2002; 16(10)1295-7. Epub 2002 Jun 7.

Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts.

Bernhard D, Skvortsov S, Tinhofer I, Hubl H, Greil R, Csordas A, Kofler R.

Cell Death Differ. 1 Oct 2001; 8(10)1014-21.

ESMO recommendations for the application of haematopoietic growth factors (hGFs).

Greil, R.

Ann Oncol. 1 Sep 2001; 12(9)1219-20.

Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2.

Tinhofer I, Bernhard D, Senfter M, Anether G, Loeffler M, Kroemer G, Kofler R, Csordas A, Greil R.

FASEB J. 1 Jun 2001; 15(9)1613-5.

Interleukin-15 as a potential costimulatory cytokine in CD154 gene therapy of chronic lymphocytic leukemia.

Anether G, Marschitz I, Tinhofer I, Greil R.

Blood. 15 Jan 2001; 99(2)722-3.